143 related articles for article (PubMed ID: 9298807)
1. Common patterns of genetic evolution in human solid tumors.
Shackney SE; Shankey TV
Cytometry; 1997 Sep; 29(1):1-27. PubMed ID: 9298807
[TBL] [Abstract][Full Text] [Related]
2. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
[TBL] [Abstract][Full Text] [Related]
3. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
Shackney SE; Pollice AA; Smith CA; Janocko LE; Sweeney L; Brown KA; Singh SG; Gu L; Yakulis R; Lucke JF
Clin Cancer Res; 1998 Apr; 4(4):913-28. PubMed ID: 9563885
[TBL] [Abstract][Full Text] [Related]
4. Preferred genetic evolutionary sequences in human breast cancer: a case study.
Shackney SE; Smith CA; Pollice AA; Janocko LE; Singh SG; Groft DW; Brown KA; Hartsock RJ
Cytometry; 1995 Sep; 21(1):6-13. PubMed ID: 8529472
[TBL] [Abstract][Full Text] [Related]
5. Genetic evolutionary staging of early non-small cell lung cancer: the P53 --> HER-2/NEU --> ras sequence.
Shackney SE; Smith CA; Pollice A; Levitt M; Magovern JA; Wiechmann RJ; Silverman J; Sweeney L; Landreneau RJ
J Thorac Cardiovasc Surg; 1999 Aug; 118(2):259-67. PubMed ID: 10424999
[TBL] [Abstract][Full Text] [Related]
6. The accumulation of multiple genetic abnormalities in individual tumor cells in human breast cancers: clinical prognostic implications.
Shackney SE; Pollice AA; Smith CA; Alston L; Singh SG; Janocko LE; Brown KA; Petruolo S; Groft DW; Yakulis R; Hartsock RJ
Cancer J Sci Am; 1996; 2(2):106-13. PubMed ID: 9166508
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite-stable diploid carcinoma: a biologically distinct and aggressive subset of sporadic colorectal cancer.
Hawkins NJ; Tomlinson I; Meagher A; Ward RL
Br J Cancer; 2001 Jan; 84(2):232-6. PubMed ID: 11161382
[TBL] [Abstract][Full Text] [Related]
8. Aneuploidy in breast cancer: a fluorescence in situ hybridization study.
Shackney SE; Singh SG; Yakulis R; Smith CA; Pollice AA; Petruolo S; Waggoner A; Hartsock RJ
Cytometry; 1995 Dec; 22(4):282-91. PubMed ID: 8749778
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
10. Genomic instability and apoptosis are frequent in p53 deficient young mice.
Fukasawa K; Wiener F; Vande Woude GF; Mai S
Oncogene; 1997 Sep; 15(11):1295-302. PubMed ID: 9315097
[TBL] [Abstract][Full Text] [Related]
11. Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma.
Xie D; Sham JS; Zeng WF; Lin HL; Bi J; Che LH; Hu L; Zeng YX; Guan XY
Hum Pathol; 2005 Jul; 36(7):777-83. PubMed ID: 16084947
[TBL] [Abstract][Full Text] [Related]
12. Comparison of features of human lung cancer cell lines and their corresponding tumors.
Wistuba II; Bryant D; Behrens C; Milchgrub S; Virmani AK; Ashfaq R; Minna JD; Gazdar AF
Clin Cancer Res; 1999 May; 5(5):991-1000. PubMed ID: 10353731
[TBL] [Abstract][Full Text] [Related]
13. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
[TBL] [Abstract][Full Text] [Related]
14. The molecular and cellular basis of human lung cancer.
Gazdar AF
Anticancer Res; 1994; 14(1B):261-7. PubMed ID: 8166465
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
[TBL] [Abstract][Full Text] [Related]
16. Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease.
Behrens C; Travis LB; Wistuba II; Davis S; Maitra A; Clarke EA; Lynch CF; Glimelius B; Wiklund T; Tarone R; Gazdar AF
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1027-35. PubMed ID: 11045784
[TBL] [Abstract][Full Text] [Related]
17. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
18. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer.
Rennstam K; Baldetorp B; Kytölä S; Tanner M; Isola J
Cancer Res; 2001 Feb; 61(3):1214-9. PubMed ID: 11221853
[TBL] [Abstract][Full Text] [Related]
20. Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization.
Liu HL; Gandour-Edwards R; Lara PN; de Vere White R; LaSalle JM
Cancer J; 2001; 7(5):395-403. PubMed ID: 11693898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]